Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Allarity Therapeutics logo

Allarity Therapeutics

Recent Finacing

Debt

Recent Raise

$20M

Allarity Therapeutics is a Copenhagen-based biotech company developing precision oncology drugs and companion diagnostics, led by its Phase-2 candidate Stenoparib for advanced ovarian cancer.

Founded 2004
Massachusetts, United States
1-10
Publicly Traded
allarity.com
PitchBook

Highlights

Focus Areas

Biotechnology
Health Care
Health Diagnostics
Oncology
Pharmaceutical

Recent Investors

S
3i Fund logo

Financials

$100M

Valuation as of 05/21/2021

$40M

Total Raised

2

Funding rounds

1

Investor


Team

Upgrade to view the team

See the team members at Allarity Therapeutics.